These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15294877)

  • 21. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.
    Superti-Furga A; Hästbacka J; Wilcox WR; Cohn DH; van der Harten HJ; Rossi A; Blau N; Rimoin DL; Steinmann B; Lander ES; Gitzelmann R
    Nat Genet; 1996 Jan; 12(1):100-2. PubMed ID: 8528239
    [No Abstract]   [Full Text] [Related]  

  • 22. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.
    Czarny-Ratajczak M; Lohiniva J; Rogala P; Kozlowski K; Perälä M; Carter L; Spector TD; Kolodziej L; Seppänen U; Glazar R; Królewski J; Latos-Bielenska A; Ala-Kokko L
    Am J Hum Genet; 2001 Nov; 69(5):969-80. PubMed ID: 11565064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.
    Rossi A; Bonaventure J; Delezoide AL; Cetta G; Superti-Furga A
    J Biol Chem; 1996 Aug; 271(31):18456-64. PubMed ID: 8702490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation.
    Superti-Furga A; Neumann L; Riebel T; Eich G; Steinmann B; Spranger J; Kunze J
    J Med Genet; 1999 Aug; 36(8):621-4. PubMed ID: 10465113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysplastic histogenesis of cartilage growth plate by alteration of sulphation pathway: a transgenic model.
    Cornaglia AI; Casasco A; Casasco M; Riva F; Necchi V
    Connect Tissue Res; 2009; 50(4):232-42. PubMed ID: 19637059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New intermediate phenotype between MED and DD caused by compound heterozygous mutations in the DTDST gene.
    Czarny-Ratajczak M; Bieganski T; Rogala P; Glowacki M; Trzeciak T; Kozlowski K
    Am J Med Genet A; 2010 Dec; 152A(12):3036-42. PubMed ID: 21077204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia.
    Mégarbané A; Haddad FA; Haddad-Zebouni S; Achram M; Eich G; Le Merrer M; Superti-Furga A
    Clin Genet; 1999 Jul; 56(1):71-6. PubMed ID: 10466420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly.
    Galante LL; Schwarzbauer JE
    J Cell Biol; 2007 Dec; 179(5):999-1009. PubMed ID: 18056413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Pendred syndrome gene encodes a chloride-iodide transport protein.
    Scott DA; Wang R; Kreman TM; Sheffield VC; Karniski LP
    Nat Genet; 1999 Apr; 21(4):440-3. PubMed ID: 10192399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from a transgenic mouse model on the role of SLC26A2 in health and disease.
    Forlino A; Gualeni B; Pecora F; Della Torre S; Piazza R; Tiveron C; Tatangelo L; Superti-Furga A; Cetta G; Rossi A
    Novartis Found Symp; 2006; 273():193-206; discussion 206-12, 261-4. PubMed ID: 17120769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation.
    Macías-Gómez NM; Mégarbané A; Leal-Ugarte E; Rodríguez-Rojas LX; Barros-Núñez P
    Am J Med Genet A; 2004 Aug; 129A(2):190-2. PubMed ID: 15316973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-glycosylation of the Xenopus laevis ClC-5 protein plays a role in cell surface expression, affecting transport activity at the plasma membrane.
    Schmieder S; Bogliolo S; Ehrenfeld J
    J Cell Physiol; 2007 Feb; 210(2):479-88. PubMed ID: 17111367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6.
    Imauchi Y; Lombès M; Lainé P; Sterkers O; Ferrary E; Grayeli AB
    Laryngoscope; 2006 Sep; 116(9):1647-50. PubMed ID: 16954997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A compound heterozygote SLC26A2 mutation resulting in robin sequence, mild limbs shortness, accelerated carpal ossification, and multiple epiphysial dysplasia in two Brazilian sisters. A new intermediate phenotype between diastrophic dysplasia and recessive multiple epiphyseal dysplasia.
    Zechi-Ceide RM; Moura PP; Raskin S; Richieri-Costa A; Guion-Almeida ML
    Am J Med Genet A; 2013 Aug; 161A(8):2088-94. PubMed ID: 23840040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical consequences of sedlin mutations that cause spondyloepiphyseal dysplasia tarda.
    Choi MY; Chan CC; Chan D; Luk KD; Cheah KS; Tanner JA
    Biochem J; 2009 Sep; 423(2):233-42. PubMed ID: 19650763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W.
    Ballhausen D; Bonafé L; Terhal P; Unger SL; Bellus G; Classen M; Hamel BC; Spranger J; Zabel B; Cohn DH; Cole WG; Hecht JT; Superti-Furga A
    J Med Genet; 2003 Jan; 40(1):65-71. PubMed ID: 12525546
    [No Abstract]   [Full Text] [Related]  

  • 37. Autosomal recessive multiple epiphyseal dysplasia in a Korean girl caused by novel compound heterozygous mutations in the DTDST (SLC26A2) gene.
    Cho TJ; Kim OH; Lee HR; Shin SJ; Yoo WJ; Park WY; Park SS; Cho SI; Choi IH
    J Korean Med Sci; 2010 Jul; 25(7):1105-8. PubMed ID: 20592910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
    Chen TL; Posey KL; Hecht JT; Vertel BM
    J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type and mutant ferroportins do not form oligomers in transfected cells.
    Gonçalves AS; Muzeau F; Blaybel R; Hetet G; Driss F; Delaby C; Canonne-Hergaux F; Beaumont C
    Biochem J; 2006 Jun; 396(2):265-75. PubMed ID: 16457665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
    Wang Y; Taroni F; Garavaglia B; Longo N
    Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.